Home Industries Reports Services About Us Publisher Contact us

+918421517810

+442921251543

+918421517810

+442921251543

Dynamics in Post-pandemic Global Biosimilar Industry: Supply and Demand, Markets and Prices 2021-2027

Type: PDF

Status: Published

Categories: Aerospace and Defence

Report Code : OTHER2111178

No. of Pages : 160

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Biosimilar market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Biosimilar market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Human Growth Hormones Monoclonal Antibodies Insulin Peptides Erythropoietin Others Segmented by End User/Segment Oncology Chronic and Autoimmune Diseases Growth Hormone Deficiency Infectious Diseases Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Pfizer Novartis Intas Pharmaceuticals Limited Genor BioPharma Dr. Reddy’s Laboratories Coherus BioSciences Celltrion Boehringer Ingelheim BioXpress Therapeutics Biocon BIOCAD Allergan plc
List of Figures

Figure Biosimilar Picture
Figure Global Biosimilar Sales Volume and Growth Rate (2016-2027)
Figure Global Biosimilar Sales Value and Growth Rate (2016-2027)
Figure Global Biosimilar Sales Value CAGR (2020-2027) by Region
Figure Global Biosimilar Sales Volume Market Share by Company, 2020
Figure Global Biosimilar Sales Value Market Share by Company, 2020
Figure Global Biosimilar Sales Value and Growth Rate (2016-2027)
Figure Product Picture of Human Growth Hormones
Figure Product Picture of Monoclonal Antibodies
Figure Product Picture of Insulin
Figure Product Picture of Peptides
Figure Product Picture of Erythropoietin
Figure Product Picture of Others
Figure Global Biosimilar Sales Volume Market Share by Category, 2020
Figure Global Biosimilar Sales Value Market Share by Category, 2020
Figure North America Biosimilar Sales Volume Market Share by Category, 2020
Figure Europe Biosimilar Sales Volume Market Share by Category, 2020
Figure Asia Pacific Biosimilar Sales Volume Market Share by Category, 2020
Figure Central & South America Biosimilar Sales Volume Market Share by Category, 2020
Figure Middle East & Africa Biosimilar Sales Volume Market Share by Category, 2020
Figure Biosimilar in Oncology
Figure Global Biosimilar Market: Oncology (2016-2021)
Figure Biosimilar in Chronic and Autoimmune Diseases
Figure Global Biosimilar Market: Chronic and Autoimmune Diseases (2016-2021)
Figure Biosimilar in Growth Hormone Deficiency
Figure Global Biosimilar Market: Growth Hormone Deficiency (2016-2021)
Figure Biosimilar in Infectious Diseases
Figure Global Biosimilar Market: Infectious Diseases (2016-2021)
Figure Biosimilar in Others
Figure Global Biosimilar Market: Others (2016-2021)
Figure Global Biosimilar Sales Volume Market Share by End User/Segment, 2020
Figure Global Biosimilar Sales Value Market Share by End User/Segment, 2020
Figure North America Biosimilar Sales Volume Market Share by End User/Segment, 2020
Figure Europe Biosimilar Sales Volume Market Share by End User/Segment, 2020
Figure Asia Pacific Biosimilar Sales Volume Market Share by End User/Segment, 2020
Figure Central & South America Biosimilar Sales Volume Market Share by End User/Segment, 2020
Figure Middle East & Africa Biosimilar Sales Volume Market Share by End User/Segment, 2020
Figure Global Biosimilar Sales Volume Market Share by Region (2016-2021)
Figure Global Biosimilar Sales Value Market Share by Region (2016-2021)
Figure North America Biosimilar Sales Volume Status (2016-2021)
Figure North America Biosimilar Sales Value Status (2016-2021)
Figure Europe Biosimilar Sales Volume Status (2016-2021)
Figure Europe Biosimilar Sales Value Status (2016-2021)
Figure Asia Pacific Biosimilar Sales Volume Status (2016-2021)
Figure North America Biosimilar Sales Value Status (2016-2021)
Figure Central & South America Biosimilar Sales Volume Status (2016-2021)
Figure Europe Biosimilar Sales Value Status (2016-2021)
Figure Middle East & Africa Biosimilar Sales Volume Status (2016-2021)
Figure China Biosimilar Sales Value Status (2016-2021)
Figure North America Biosimilar Sales Volume Market Share by Country, 2020
Figure Japan Biosimilar Sales Value Status (2016-2021)
Figure United States Biosimilar Sales Volume Status (2016-2021)
Figure Asia Other Biosimilar Sales Value Status (2016-2021)
Figure Canada Biosimilar Sales Volume Status (2016-2021)
Figure Canada Biosimilar Sales Value Status (2016-2021)
Figure Mexico Biosimilar Sales Volume Status (2016-2021)
Figure Mexico Biosimilar Sales Value Status (2016-2021)
Figure Europe Biosimilar Sales Volume Market Share by Country, 2020
Figure Europe Biosimilar Value Market Share by Country, 2020
Figure Germany Biosimilar Sales Volume Status (2016-2021)
Figure Germany Biosimilar Sales Value Status (2016-2021)
Figure France Biosimilar Sales Volume Status (2016-2021)
Figure France Biosimilar Sales Value Status (2016-2021)
Figure UK Biosimilar Sales Volume Status (2016-2021)
Figure UK Biosimilar Sales Value Status (2016-2021)
Figure Italy Biosimilar Sales Volume Status (2016-2021)
Figure Italy Biosimilar Sales Value Status (2016-2021)
Figure Russia Biosimilar Sales Volume Status (2016-2021)
Figure Russia Biosimilar Sales Value Status (2016-2021)
Figure Spain Biosimilar Sales Volume Status (2016-2021)
Figure Spain Biosimilar Sales Value Status (2016-2021)
Figure Asia Pacific Biosimilar Sales Volume Market Share by Country, 2020
Figure Asia Pacific Biosimilar Value Market Share by Country, 2020
Figure China Biosimilar Sales Volume Status (2016-2021)
Figure China Biosimilar Sales Value Status (2016-2021)
Figure Japan Biosimilar Sales Volume Status (2016-2021)
Figure Japan Biosimilar Sales Value Status (2016-2021)
Figure Korea Biosimilar Sales Volume Status (2016-2021)
Figure Korea Biosimilar Sales Value Status (2016-2021)
Figure Southeast Asia Biosimilar Sales Volume Status (2016-2021)
Figure Southeast Asia Biosimilar Sales Value Status (2016-2021)
Figure India Biosimilar Sales Volume Status (2016-2021)
Figure India Biosimilar Sales Value Status (2016-2021)
Figure Australasia Biosimilar Sales Volume Status (2016-2021)
Figure Australasia Biosimilar Sales Value Status (2016-2021)
Figure Central & South America Biosimilar Sales Volume Market Share by Country, 2020
Figure Central & South America Biosimilar Sales Value Market Share by Country, 2020
Figure Brazil Biosimilar Sales Volume Status (2016-2021)
Figure Brazil Biosimilar Sales Value Status (2016-2021)
Figure Argentina Biosimilar Sales Volume Status (2016-2021)
Figure Argentina Biosimilar Sales Value Status (2016-2021)
Figure Colombia Biosimilar Sales Volume Status (2016-2021)
Figure Colombia Biosimilar Sales Value Status (2016-2021)
Figure Middle East & Africa Biosimilar Sales Volume Market Share by Country, 2020
Figure Middle East & Africa Biosimilar Value Market Share by Country, 2020
Figure Iran Biosimilar Sales Volume Status (2016-2021)
Figure Iran Biosimilar Sales Value Status (2016-2021)
Figure South Africa Biosimilar Sales Volume Status (2016-2021)
Figure South Africa Biosimilar Sales Value Status (2016-2021)
Figure Israel Biosimilar Sales Volume Status (2016-2021)
Figure Israel Biosimilar Sales Value Status (2016-2021)
Figure Turkey Biosimilar Sales Volume Status (2016-2021)
Figure Turkey Biosimilar Sales Value Status (2016-2021)
Figure Saudi Arabia Biosimilar Sales Volume Status (2016-2021)
Figure Saudi Arabia Biosimilar Sales Value Status (2016-2021)
Figure Biosimilar Supply Chain Analysis
Figure Biosimilar Production Process Chart Analysis
Figure Biosimilar Manufacturing Cost Analysis
Figure Global Biosimilar Sales Volume Forecast (2022-2027)
Figure Global Biosimilar Sales Value Forecast (2022-2027)
Figure North America Biosimilar Sales Volume Forecast (2022-2027)
Figure North America Biosimilar Sales Value Forecast (2022-2027)
Figure Global Biosimilar Sales Value Growth Rate Forecast (2022-2027)
Figure Europe Biosimilar Sales Value Forecast (2022-2027)
Figure Asia Pacific Biosimilar Sales Volume Forecast (2022-2027)
Figure North America Biosimilar Sales Value Forecast (2022-2027)
Figure Central & South America Biosimilar Sales Volume Forecast (2022-2027)
Figure Europe Biosimilar Sales Value Forecast (2022-2027)
Figure Middle East & Africa Biosimilar Sales Volume Forecast (2022-2027)
Figure China Biosimilar Sales Value Forecast (2022-2027)
Figure Japan Biosimilar Sales Value Forecast (2022-2027)
Figure Asia Other Biosimilar Sales Value Forecast (2022-2027)
Figure Pfizer Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Pfizer Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Novartis Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Novartis Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Intas Pharmaceuticals Limited Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Intas Pharmaceuticals Limited Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Genor BioPharma Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Genor BioPharma Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Dr. Reddy’s Laboratories Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Dr. Reddy’s Laboratories Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Coherus BioSciences Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Coherus BioSciences Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Celltrion Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Celltrion Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Boehringer Ingelheim Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Boehringer Ingelheim Biosimilar Sales Value Market Share Globally (2019-2021)
Figure BioXpress Therapeutics Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure BioXpress Therapeutics Biosimilar Sales Value Market Share Globally (2019-2021)
Figure Biocon Biosimilar Sales Volume Market Share Globally (2019-2021)
Figure Biocon Biosimilar Sales Value Market Share Globally (2019-2021)
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Biosimilar Market Status and Forecast (2016-2027) 1.3.2 Global Biosimilar Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Biosimilar Supply by Company 2.1 Global Biosimilar Sales Volume by Company 2.2 Global Biosimilar Sales Value by Company 2.3 Global Biosimilar Price by Company 2.4 Biosimilar Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Biosimilar Market Status by Category 3.1 Biosimilar Category Introduction 3.1.1 Human Growth Hormones 3.1.2 Monoclonal Antibodies 3.1.3 Insulin 3.1.4 Peptides 3.1.5 Erythropoietin 3.1.6 Others 3.2 Global Biosimilar Market by Category 3.2.1 Global Biosimilar Sales Volume by Category (2016-2021) 3.2.2 Global Biosimilar Sales Value by Category (2016-2021) 3.2.3 Global Biosimilar Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Biosimilar Market Status by End User/Segment 4.1 Biosimilar Segment by End User/Segment 4.1.1 Oncology 4.1.2 Chronic and Autoimmune Diseases 4.1.3 Growth Hormone Deficiency 4.1.4 Infectious Diseases 4.1.5 Others 4.2 Global Biosimilar Market by End User/Segment 4.2.1 Global Biosimilar Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Biosimilar Sales Value by End User/Segment (2016-2021) 4.2.3 Global Biosimilar Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Biosimilar Market Status by Region 5.1 Global Biosimilar Market by Region 5.1.1 Global Biosimilar Sales Volume by Region 5.1.2 Global Biosimilar Sales Value by Region 5.2 North America Biosimilar Market Status 5.3 Europe Biosimilar Market Status 5.4 Asia Pacific Biosimilar Market Status 5.5 Central & South America Biosimilar Market Status 5.6 Middle East & Africa Biosimilar Market Status6 North America Biosimilar Market Status 6.1 North America Biosimilar Market by Country 6.1.1 North America Biosimilar Sales Volume by Country (2016-2021) 6.1.2 North America Biosimilar Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Biosimilar Market Status 7.1 Europe Biosimilar Market by Country 7.1.1 Europe Biosimilar Sales Volume by Country (2016-2021) 7.1.2 Europe Biosimilar Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Biosimilar Market Status 8.1 Asia Pacific Biosimilar Market by Country 8.1.1 Asia Pacific Biosimilar Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Biosimilar Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Biosimilar Market Status 9.1 Central & South America Biosimilar Market by Country 9.1.1 Central & South America Biosimilar Sales Volume by Country (2016-2021) 9.1.2 Central & South America Biosimilar Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Biosimilar Market Status 10.1 Middle East & Africa Biosimilar Market by Country 10.1.1 Middle East & Africa Biosimilar Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Biosimilar Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Biosimilar Manufacturing Cost Analysis 11.5 Biosimilar Sales Channel and Distributors Analysis 11.5.1 Biosimilar Sales Channel 11.5.2 Biosimilar Distributors 11.6 Biosimilar Downstream Major Buyers12 Global Biosimilar Market Forecast by Category and by End User/Segment 12.1 Global Biosimilar Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Biosimilar Forecast by Category 12.2.1 Global Biosimilar Sales Volume Forecast by Category 12.2.2 Global Biosimilar Sales Value Forecast by Category 12.2.3 Global Biosimilar Price Forecast by Category 12.3 Global Biosimilar Forecast by End User/Segment 12.3.1 Global Biosimilar Sales Volume Forecast by End User/Segment 12.3.2 Global Biosimilar Sales Value Forecast by End User/Segment 12.3.3 Global Biosimilar Price Forecast by End User/Segment13 Global Biosimilar Market Forecast by Region/Country 13.1 Global Biosimilar Market Forecast by Region (2022-2027) 13.1.1 Global Biosimilar Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Biosimilar Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Pfizer 14.1.1 Company Information 14.1.2 Biosimilar Product Introduction 14.1.3 Pfizer Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Novartis 14.2.1 Company Information 14.2.2 Biosimilar Product Introduction 14.2.3 Novartis Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Intas Pharmaceuticals Limited 14.3.1 Company Information 14.3.2 Biosimilar Product Introduction 14.3.3 Intas Pharmaceuticals Limited Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Genor BioPharma 14.4.1 Company Information 14.4.2 Biosimilar Product Introduction 14.4.3 Genor BioPharma Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Dr. Reddy’s Laboratories 14.5.1 Company Information 14.5.2 Biosimilar Product Introduction 14.5.3 Dr. Reddy’s Laboratories Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Coherus BioSciences 14.6.1 Company Information 14.6.2 Biosimilar Product Introduction 14.6.3 Coherus BioSciences Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Celltrion 14.7.1 Company Information 14.7.2 Biosimilar Product Introduction 14.7.3 Celltrion Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Boehringer Ingelheim 14.8.1 Company Information 14.8.2 Biosimilar Product Introduction 14.8.3 Boehringer Ingelheim Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 BioXpress Therapeutics 14.9.1 Company Information 14.9.2 Biosimilar Product Introduction 14.9.3 BioXpress Therapeutics Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Biocon 14.10.1 Company Information 14.10.2 Biosimilar Product Introduction 14.10.3 Biocon Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 BIOCAD 14.12 Allergan plc15 Conclusion16 Methodology

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution
Market Precise

Published On: 04-12-21

Single User

US$ 2980

Multi User

US$ 4470

Corporate User

US$ 5960

Dynamics in Post-pandemic Global Biosimilar Indust...

RD Code : OTHER2111178